112 related articles for article (PubMed ID: 6497779)
1. Microsomal protein synthesis and induction of cytochrome P-450 in cirrhotic rat liver.
Farrell GC; Zaluzny L
Aust J Exp Biol Med Sci; 1984 Jun; 62 ( Pt 3)():291-301. PubMed ID: 6497779
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model.
Murray M; Zaluzny L; Farrell GC
Biochem Pharmacol; 1986 Jun; 35(11):1817-24. PubMed ID: 3718530
[TBL] [Abstract][Full Text] [Related]
3. Impaired androgen 16 alpha-hydroxylation in hepatic microsomes from carbon tetrachloride-cirrhotic male rats.
Murray M; Zaluzny L; Farrell GC
Gastroenterology; 1987 Jul; 93(1):141-7. PubMed ID: 3582901
[TBL] [Abstract][Full Text] [Related]
4. In micronodular cirrhosis, hepatocytes retain a normal C-25 hydroxylation capacity toward vitamin D3: a study using the rat carbon tetrachloride-induced cirrhotic model.
Dubé C; Vallières S; Ethier C; Benbrahim N; Tremblay C; Gascon-Barré M
Hepatology; 1991 Mar; 13(3):489-99. PubMed ID: 1847894
[TBL] [Abstract][Full Text] [Related]
5. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
6. Unimpaired induction of drug-metabolizing enzymes in hepatocytes isolated from rats with micronodular cirrhosis.
Wu ZQ; Piché D; Vallières S; Huet PM; Gascon-Barré M
Can J Physiol Pharmacol; 1991 Mar; 69(3):426-36. PubMed ID: 2059906
[TBL] [Abstract][Full Text] [Related]
7. Hepatic heme metabolism and cytochrome P450 in cirrhotic rat liver.
Farrell GC; Zaluzny L
Gastroenterology; 1985 Jul; 89(1):172-9. PubMed ID: 4007401
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific modulation of hepatic covalent DNA modifications (I-compounds) by the cytochrome P450 inducer, pregnenolone-16 alpha-carbonitrile.
Moorthy B; van Golen KL; Randerath K
Toxicol Appl Pharmacol; 1992 Apr; 113(2):218-26. PubMed ID: 1561630
[TBL] [Abstract][Full Text] [Related]
9. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
10. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
White IN; Muller-Eberhard U
Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
[TBL] [Abstract][Full Text] [Related]
11. Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver.
Okuno H; Hazama H; Murase T; Shiozaki Y; Sameshima Y
Jpn J Pharmacol; 1986 Jul; 41(3):363-71. PubMed ID: 3761752
[TBL] [Abstract][Full Text] [Related]
12. Changes in concentrations of respiratory components and cytochrome oxidase activity in mitochondria obtained from carbon tetrachloride-induced cirrhotic rat liver.
Morimoto T; Tanaka A; Taki Y; Noguchi M; Yokoo N; Nishihira T; Nishikawa K; Yamamoto S; Nitta N; Jikkoh A
Clin Sci (Lond); 1988 May; 74(5):485-9. PubMed ID: 2836123
[TBL] [Abstract][Full Text] [Related]
13. Improvement in liver fibrosis, functionality and hemodynamics in CCI4-cirrhotic rats after injection of the Liver Growth Factor.
Díaz-Gil JJ; Muñoz J; Albillos A; Rúa C; Machín C; García-Cañero R; Cereceda RM; Guijarro MC; Trilla C; Escartín P
J Hepatol; 1999 Jun; 30(6):1065-72. PubMed ID: 10406185
[TBL] [Abstract][Full Text] [Related]
14. Rate-limiting steps in drug metabolism by microsomes from CCl-4-cirrhotic rat liver.
Tsyrlov IB; Lyakhovich VV
Chem Biol Interact; 1975 Feb; 10(2):77-89. PubMed ID: 1126002
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial function in carbon tetrachloride-induced cirrhosis in the rat. Qualitative and quantitative defects.
Krähenbühl S; Stucki J; Reichen J
Biochem Pharmacol; 1989 May; 38(10):1583-8. PubMed ID: 2730674
[TBL] [Abstract][Full Text] [Related]
16. Abnormal lipid composition of microsomes from cirrhotic rat liver--does it contribute to decreased microsomal function?
Reichen J; Buters JT; Sojcic Z; Roos FJ
Experientia; 1992 May; 48(5):482-6. PubMed ID: 1601113
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities.
Fentem JH; Fry JR
Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265
[TBL] [Abstract][Full Text] [Related]
18. Treatment of liver cirrhosis with microsomal enzyme-inducing compound in the rat.
Saarni HU; Arranto AJ; Rautio A; Sotaniemi EA
J Hepatol; 1985; 1(5):501-11. PubMed ID: 2932501
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of the suicidal, reductive inactivation of microsomal cytochrome P-450 by carbon tetrachloride.
Manno M; De Matteis F; King LJ
Biochem Pharmacol; 1988 May; 37(10):1981-90. PubMed ID: 3377806
[TBL] [Abstract][Full Text] [Related]
20. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
